arrow_back Civic Audit
Share share

Preventing Overdoses: Increased Access to Treatment and Lifesaving Medications

This act aims to expand access to opioid overdose prevention and addiction treatment programs. It means more funding for helping individuals with addiction, including for lifesaving medications and therapies. The changes will make it easier for states, tribes, and local communities to obtain financial support for these initiatives.
Key points
More funding for overdose prevention programs: Funds will be available until 2027, ensuring continuous support.
Wider access to lifesaving medications: These medications will be more readily available, including for patients prescribed both opioids and benzodiazepines.
Support for overdose survivors: New protocols will connect patients who have experienced an overdose with appropriate treatment and support.
Easier access for local communities: States, tribes, and local governments will find it simpler to obtain grants for combating the opioid crisis.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_7681
Sponsor: Rep. Hill, J. French [R-AR-2]
Process start date: 2022-05-06
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Preventing Overdoses and Saving Lives Act 2.0

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_7681.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-05-06.

What are the main provisions?

Key points include:

  • More funding for overdose prevention programs: Funds will be available until 2027, ensuring continuous support.
  • Wider access to lifesaving medications: These medications will be more readily available, including for patients prescribed both opioids and benzodiazepines.
  • Support for overdose survivors: New protocols will connect patients who have experienced an overdose with appropriate treatment and support.
  • Easier access for local communities: States, tribes, and local governments will find it simpler to obtain grants for combating the opioid crisis.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Hill, J. French [R-AR-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health